Key result
Doxycycline treatment attenuated chronic intermittent hypoxia-induced atrial fibrosis and altered MMP and miR-21/ERK signaling pathways in rats.
Why the study?
Does doxycycline reduce chronic intermittent hypoxia-induced atrial fibrosis in rats?
RCT (n=30)
randomized into three groups
Does doxycycline reduce chronic intermittent hypoxia-induced atrial fibrosis in rats?
Doxycycline attenuates chronic intermittent hypoxia-induced atrial fibrosis in a rat model, suggesting a potential mechanism involving MMP and miR-21/ERK signaling pathways.
Answers are grounded in this paper and cite their sources.
No clinical implications yet for AF or OSA; leaves open doxycycline's role in modulating MMP/miR-21 pathways for future translational research.
INTRODUCTION: Atrial structural remodeling in the form of fibrosis contributes to the arrhythmic substrate in atrial fibrillation (AF). The aim of this study was to investigate the effects of doxycycline on chronic intermittent hypoxia (CIH)-induced atrial fibrosis and the pathophysiological mechanisms underlying such changes. METHODS: A total of 30 Sprague Dawley rats were randomized into three groups: control group, CIH group, and CIH with doxycycline treatment (CIH-D) group. CIH lasted 5 hours per day for 4 weeks. CIH-D rats were administrated doxycycline for 4 weeks, while they received CIH. Masson's trichrome staining was used to determine collagen deposit in the atrial myocardium. Protein and mRNA levels of Matrix Metalloproteinase-2 (MMP-2) and -9 (MMP-9), microRNA-21 (miR-21) and its downstream target Sprouty1 (Spry1), and extracellular signal-regulated kinases 1/2 (ERK1/2) were measured using Western blotting or real-time qRT-PCR, respectively. RESULTS: Compared to the control group, the CIH group showed higher interstitial collagen fraction, increased MMP-9, miR-21, and p-ERK1/2 levels, and decreased MMP-2 and Spry1 levels. Doxycycline treatment attenuated CIH-induced atrial fibrosis, reduced MMP-2, MMP-9, miR-21, and p-ERK1/2, and increased Spry1. CONCLUSIONS: CIH treatment induced significant atrial fibrosis in our rat model, which was attenuated by doxycycline. These changes can be explained by alterations in the MMP and miR-21/ERK signaling pathways.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2018) conducted an RCT in Chronic intermittent hypoxia-induced atrial fibrosis (n=30). Doxycycline vs. Chronic intermittent hypoxia without doxycycline was evaluated on Atrial fibrosis (interstitial collagen fraction) and protein/mRNA levels of MMP-2, MMP-9, miR-21, Spry1, and ERK1/2. Doxycycline treatment attenuated chronic intermittent hypoxia-induced atrial fibrosis and altered MMP and miR-21/ERK signaling pathways in rats.
Synapse has enriched 10 related papers. Consider them for comparative context: